Researchers Receive $10M Grant to Create Computational and Informatics Tools for Glycoscience

GW and UGA researchers will build tools to support the next big data frontier: glycoscience

WASHINGTON (Feb 28, 2018) — Today, questions asked by genetic researchers are often answered using big data, through revealing larger patterns, trends, and other connections. Thanks to a multi-million dollar research project, researchers at the George Washington University (GW) and the University of Georgia (UGA) are partners in a project that will soon be able to provide a way for questions asked by those studying glycoscience to be answered by big data, as well.

“Post-translational modifications along with genomics play an important role in health and disease,” said Raja Mazumder, PhD, co-principal investigator and associate professor of biochemistry and molecular medicine at the GW School of Medicine and Health Sciences. “Using just genomics research for discovery limits scientific advancement – We may not be able to find mutations to explain the prevalence or rate of incidence of a particular disease. For that, we need to understand glycosylation, and we need the resources and tools to support this discipline.”

The National Institutes of Health has jointly awarded a $10 million U01 grant to GW and UGA to build a glycoscience informatics portal, called GlyGen, necessary for glycoscience to advance. GlyGen will also integrate glycan data with gene and protein data, to allow for more effective analysis.

Currently, understanding the roles that glycans play in diseases such as cancer involves extensive literature-based research and manual collection of data from disparate databases and websites. GlyGen will simplify this process by providing scientists with a road map that shows key relationships among diverse kinds of information, allowing them to quickly find and retrieve the most current knowledge available and make rapid progress in their glycobiology research.

“It is impossible to do meaningful glycobiology research without including information from many different disciplines, including genomics, proteomics, cell biology, developmental biology and biochemistry, to name just a few,” said William York, PhD, co-principal investigator, professor of biochemistry and molecular biology at the Franklin College of Arts and Sciences, and member of UGA’s Complex Carbohydrate Research Center.

Mazumder, York, and their research teams are working closely with researchers from the United States, Asia, Europe, and Australia to build GlyGen. This will allow them to leverage work that has already been done in the field and receive input to make sure GlyGen is accessible to researchers without a glycoscience background.

The project, titled “Computational and Informatics Tools for Research in Glycosciences,” will be funded through 2022.

Visit GlyGen for more information.

Latest News

Basil Considine, a third-year medical student at the George Washington University School of Medicine and Health Sciences (GW SMHS), addressed U.S. Food and Drug Administration (FDA) leadership, pharmaceutical representatives, and association stakeholders during a public meeting regarding the…
The George Washington University School of Medicine and Health Sciences (SMHS) recently honored a pair of accomplished faculty members, Sharad Goyal, MD, and Christina M. Puchalski, MD ’94, RESD ’97, for their academic excellence and leadership in patient care by formally bestowing them with…
The GW Department of Dermatology has been awarded a prestigious Competitive Clinical Research Grant by Eli Lilly and Company to evaluate the effectiveness of Atopic Triad (atopic dermatitis, asthma, and seasonal allergies) screening and education to reduce the burden of Atopic Dermatitis and its…